Activin and Inhibin

(R)-Casopitant ((R)-GW679769) is the isomer of Casopitant (HY-14405). Casopitant is a NK(1)-receptor antagonist. Casopitant can be used for the research of chemotherapy-induced nausea and vomiting.Form:Solid.

(R)-eIF4A3-IN-2 is a less active enantiomer of eIF4A3-IN-2. eIF4A3-IN-2 is a highly selective and noncompetitive eukaryotic initiation factor 4A-3 (eIF4A3) inhibitor with an IC 50 of 110 nM.In VitroEukaryotic initiation factor 4A-3 (eIF4A3) is an

(R)-eIF4A3-IN-2 is a less active enantiomer of eIF4A3-IN-2. eIF4A3-IN-2 is a highly selective and noncompetitive eukaryotic initiation factor 4A-3 (eIF4A3) inhibitor with an IC 50 of 110 nM.In VitroEukaryotic initiation factor 4A-3 (eIF4A3) is an

(R)-eIF4A3-IN-2 is a less active enantiomer of eIF4A3-IN-2. eIF4A3-IN-2 is a highly selective and noncompetitive eukaryotic initiation factor 4A-3 (eIF4A3) inhibitor with an IC 50 of 110 nM.In VitroEukaryotic initiation factor 4A-3 (eIF4A3) is an

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.Form:Solid.

(R)-Filanesib ((R)-ARRY-520) is the R-enantiomer of Filanesib ( HY-15187 ). Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor with an IC 50 of 6 nM.

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1 -selective inhibitor, with an IC 50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation,

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1 -selective inhibitor, with an IC 50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation,

(R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine ( HY-132821 ), is a potent phosphodiesterase 9 (PDE9) inhibitor with an IC 50 value of 0.041 μM. (R)-Irsenontrine can be used for the research of neurological diseasesForm:SolidIC50&amp: